Detalhe da pesquisa
1.
Estimating the Theoretical Cost Implications of Funding New Drugs Considered Not to Be Cost-Effective.
Value Health
; 24(10): 1402-1406, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593162
2.
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group.
Value Health
; 23(11): 1423-1426, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127011
3.
Acute herpes zoster and post herpetic neuralgia in primary care: a study of diagnosis, treatment and cost.
Eur J Clin Microbiol Infect Dis
; 37(4): 627-631, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218466
4.
Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
Br J Clin Pharmacol
; 79(6): 1000-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25521800
5.
To HTA or Not to HTA: Identifying the Factors Influencing the Rapid Review Outcome in Ireland.
Value Health
; 23(2): 274-275, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32113633
6.
Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland.
BMC Health Serv Res
; 13: 105, 2013 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23510135
7.
Proton pump inhibitors: potential cost reductions by applying prescribing guidelines.
BMC Health Serv Res
; 12: 408, 2012 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23163956
8.
The Utility of a Rapid Review Evaluation Process to a National HTA Agency.
Pharmacoeconomics
; 40(2): 203-214, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635994
9.
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland.
Eur J Health Econ
; 21(6): 895-901, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232603
10.
Health Technology Assessment of Drugs in Ireland: An Analysis of Timelines.
Pharmacoecon Open
; 4(2): 287-296, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31531843
11.
Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010.
Value Health
; 12(1): 10-5, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19040564
12.
Estimating drug costs in economic evaluations in Ireland and the UK: an analysis of practice and research recommendations.
Pharmacoeconomics
; 27(8): 635-43, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19712007
13.
A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.
Pharmacoeconomics
; 27(10): 829-46, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19803538
14.
Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017.
Pharmacoecon Open
; 3(4): 583-589, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31073976
15.
Economic evaluation of a universal childhood pneumococcal conjugate vaccination strategy in Ireland.
Value Health
; 11(5): 898-903, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18489504
16.
Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Eur J Public Health
; 18(3): 275-82, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18160389
17.
The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.
Eur J Health Econ
; 6(3): 267-73, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15977036
18.
Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.
Eur J Heart Fail
; 17(7): 672-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26139583
19.
Pricing and reimbursement of drugs in Ireland.
Eur J Health Econ
; 5(2): 190-4, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15452757
20.
The high cost of medicines in Ireland. Is it time to change the pricing mechanism?
Eur J Health Econ
; 5(4): 341-4, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15452737